Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 February 2019 | Story Rulanzen Martin | Photo Rulanzen Martin
Prof Angelique van Niekerk and CP Naude
Charl-Pierre Naudé with Prof Angelique van Niekerk after launch and discussion of his book.

Die Ongelooflike Onskuld van Dirkie Verwey is the debut novel by Charl-Pierre Naudé, research fellow in the Department of Afrikaans and Dutch, German and French at the University of the Free State (UFS).

Naudé has published four volumes of poetry and is a poet by profession. Die Ongelooflike Onskuld van Dirkie Verwey is his first leap from poetry to prose. He is also a former winner of the Ingrid Jonker Prize for poetry.

The book, published by Tafelberg, was launched on the UFS Bloemfontein Campus on Thursday 30 January 2019 where Naudé was in conversation with Dr Francois Smit, also from the Department of Afrikaans and Dutch, German and French, during which the two of them attempted to analyse the world of the main characters; however, Naudé did not want to give away too much. ”I think people should read the book,” he said.

Spiritual and physical worlds

 

“The novel is a first-person narrative told by one of the characters. I wanted to play a certain bluff to determine exactly who the author of this book was,” said Naudé. The book is not totally explicable. “I wanted the reader to feel that it is not absolutely true.”

''The book seeks to combine the spiritual and physical worlds,” said Naudé. Die Ongelooflike Onskuld van Dirkie Verwey is essentially a love story in which the two worlds merge, but nonetheless never mix.

 

Creative writing course revived

 

“The book is Charl-Pierre’s creative output which forms part of his creative writing course,” said Head of Department, Prof Angelique van Niekerk. This is the first book published after the revival of the creative writing course at the UFS in 2015 – and what a book to kick off with!

“It is of great importance for our department to have been part of this book,” Dr Smith said.

Read here the article published in Huisgenoot.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept